DUPIXENT® (dupilumab) for Moderate-to-Severe Eczema that is …
WEBDUPIXENT® (dupilumab) is a subcutaneous injectable prescription medicine for uncontrolled moderate-to-severe eczema (atopic dermatitis) in adults & children aged 6 months & older. Serious side effects can occur.
How DUPIXENT® (dupilumab) is Taken: Eczema Dosing
WEBDUPIXENT is a prescription medicine used to treat adults and children 6 months of age and older with moderate-to-severe eczema (atopic dermatitis or AD) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies.
About Dupixent
WEBDUPIXENT works by blocking two proteins that contribute to a type of inflammation that plays a major role in atopic dermatitis. DUPIXENT affects the body’s immune system to reduce the inflammation associated with moderate-to-severe eczema, which may reduce symptoms such as rash, redness, and itch.
How DUPIXENT® (dupilumab) Works for Eczema
WEBLearn how DUPIXENT® (dupilumab) works to treat a source of underlying inflammation that can contribute to uncontrolled, moderate-to-severe eczema in adults and children aged 6 months & older. Serious side effects can occur.
Frequently Asked Questions About DUPIXENT® (dupilumab)
WEBDUPIXENT® (dupilumab) is a prescription medicine used to treat people aged 6 years and older with moderate-to-severe atopic dermatitis (eczema) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies.
Take Action With DUPIXENT® (dupilumab)
WEBDUPIXENT is a prescription medicine used to treat adults and children 6 months of age and older with moderate-to-severe eczema (atopic dermatitis or AD) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies.
Doctor Discussion Guide for Eczema Patients - DUPIXENT
WEBGet your personalized discussion guide to help yourself have a productive conversation with your doctor & see if DUPIXENT® (dupilumab) for uncontrolled moderate-to-severe atopic dermatitis is right for you.
WEBDUPIXENT is medically necessary; and that I have prescribed DUPIXENT to the patient named on this form for an FDA-approved indication. I understand that my patient’s information provided to Regeneron Pharmaceuticals,
Hear Real Eczema Patient Stories | DUPIXENT® (dupilumab)
WEBLearn more about other adults and children (as young as 6 months) and their caregivers stories of uncontrolled moderate-to-severe eczema, and how they found strength and perseverance before they discovered DUPIXENT® …
DUPIXENT MyWay® Support for Patients | DUPIXENT® (dupilumab)
WEBDUPIXENT is a prescription medicine used to treat adults and children 6 months of age and older with moderate-to-severe eczema (atopic dermatitis or AD) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies.